文献速递精神分裂症与精神病性障碍

抗精神病药治疗对首发精神病突触前多巴胺合成能力的影响:一项PET研究

The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study.
PubMed 文献 · Biol Psychiatry · 2018-07-11

该前瞻性[18F]-DOPA PET研究在20例首发精神病患者中,于抗精神病药治疗前后测量纹状体多巴胺合成能力与PANSS症状,发现治疗未显著改变全纹状体多巴胺合成能力(p=.47),且合成能力变化与阳性症状变化无显著相关(ρ=.35,p=.13)。

要点

  • 抗精神病药治疗未显著改变首发精神病患者全纹状体多巴胺合成能力(p=.47)。
  • 多巴胺合成能力变化与阳性症状变化无显著关系(ρ=.35,p=.13)。
  • 疗效可能不通过改变突触前多巴胺合成能力介导。

核心结论

  • 抗精神病药治疗未改变首发精神病患者纹状体多巴胺合成能力,疗效并非由该多巴胺功能指标的变化所介导。

研究设计与样本

  • 前瞻性[18F]-DOPA PET研究,纳入20例抗精神病药未使用/停用的首发精神病患者,其中17例治疗期依从治疗剂量。
  • 在抗精神病药治疗前及至少5周治疗后测量多巴胺合成能力(流入速率常数)与PANSS症状。

主要发现

  • 全纹状体多巴胺合成能力在治疗前后无显著变化(p=.47),丘脑和中脑亦无显著变化。
  • 多巴胺合成能力变化与阳性症状变化无显著关系(ρ=.35,p=.13),与阴性症状及总症状变化亦无显著关系。

临床怎么用

  • 提示临床不宜以突触前多巴胺合成能力的变化作为抗精神病药疗效的预期生物标志物。

局限性

  • 样本量较小(20例,17例依从治疗剂量),统计效能有限,阴性结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Elevated striatal dopamine synthesis capacity has been implicated in the etiology and antipsychotic response in psychotic illness. The effects of antipsychotic medication on dopamine synthesis capacity are poorly understood, and no prospective studies have examined this question in a solely first-episode psychosis sample. Furthermore, it is unknown whether antipsychotic efficacy is linked to reductions in dopamine synthesis capacity. We conducted a prospective [18F]-dihydroxyphenyl-L-alanine positron emission tomography study in antipsychotic naïve/free people with first-episode psychosis commencing antipsychotic treatment. METHODS: Dopamine synthesis capacity (indexed as influx rate constant) and clinical symptoms (measured using Positive and Negative Syndrome Scale) were measured before and after at least 5 weeks of antipsychotic treatment in people with first-episode psychosis. Data from a prior study indicated that a sample size of 13 would have >80% power to detect a statistically significant change in dopamine synthesis capacity at alpha = .05 (two tailed). RESULTS: A total of 20 people took part in the study, 17 of whom were concordant with antipsychotic medication at therapeutic doses. There was no significant effect of treatment on dopamine synthesis capacity in the whole striatum (p = .47), thalamus, or midbrain, nor was there any significant relationship between change in dopamine synthesis capacity and change in positive (ρ = .35, p = .13), negative, or total psychotic symptoms. CONCLUSIONS: Dopamine synthesis capacity is unaltered by antipsychotic treatment, and therapeutic effects are not mediated by changes in this aspect of dopaminergic function.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Jauhar S, Veronese M, Nour MM, et al. The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study. Biol Psychiatry. 2018. PMID: 30122287. doi:10.1016/j.biopsych.2018.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。